Teva is primed for a big bounce after years of underperformance, Barclays says
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva shed 37% of Israel workforce in two years - Globes
Red Day: The Tel Aviv Stock Exchange fell 2.9%, “This is not a local story”
Business in Brief: Teva patent dispute with Swiss firm reaches U.S. Supreme Court - Business - Haaretz.com
Business in Brief: Teva Pharm to move headquarters to Tel Aviv - Business - Haaretz.com
Teva to cut 14,000 jobs | Business | Chemistry World
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Phillip Frost, billionaire and chairman of Teva Pharmaceutical... News Photo - Getty Images
Teva pharmaceuticals Stock Photo - Alamy
Teva Chooses New Israeli Headquarters in Tel Aviv | Ctech
Tel Aviv Stock Exchange - Wikiwand
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
UBS raises Teva price target - Globes
Comeback: Teva released its reports and jumped in Tel Aviv by 18% | Israel today - The Limited Times
Teva Stock Price Rises - Wise Money Israel
Teva Surges Once Again on $1.1 Billion Sale and New CEO - TheStreet
Teva stock drops 13% as Tel Aviv trade begins - Israel News - The Jerusalem Post
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Teva will lease new 17-floor Tel Aviv HQ from Vitania - Globes
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
